Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of radiation-induced dermatitis in cancer patients
RBR-92cts3Phase 3Recruiting
- Sponsor
- Universidade de Brasília
- Start
- May 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of chamomilla recutita in radiodermatitis (3 arms), sponsored by Universidade de Brasília. Started May 2019; status: recruiting.
02
Drugs
chamomilla recutita
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on RBR-92cts3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-92cts3.